Summary &horbar; Essential fatty acids (EFA), which are not synthesized in animal and human tissues, belong to the n-6 and n-3 families of polyunsaturated fatty acids (PUFA), derived from linoleic acid (LA,) and a-linolenic acid (LNA,. Optimal requirements are 3-6% of ingested energy for LA and 0.5-1% for LNA in adults. Requirements in LNA are higher in development. Dietary sources of LA and LNA are principally plants, while arachidonic acid (AA,) is found in products from terrestrian animals, and eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) 
INTRODUCTION
The properties of lipids are those of their component fatty acids. These can be divided, according to their chemical structure, into 2 broad groups: saturated and unsaturated fatty acids. The latter can then be further sub-divided, according to their biological properties, into 2 different narrower groups: mono-and polyunsaturated fatty acids (PUFA) . The latter group is composed of 4 families of fatty acids. The first 2 are the palmitoleic (n-7) and oleic (n-9) families which are not essential since they are synthesized de novo in most cells. On the contrary, the next 2 families, namely the linoleic (n-6) and linolenic (n-3) families, cannot be synthesized de novo by animal cells and hence must be provided in the diet. All the members of these 2 independent families derive from their respective precursors, linolenic acid (LA, ) and a-linolenic acid (LNA, by alternate desaturation-elongation reactions (fig 1) (Sprecher, 1981 ) .
In the absence of these dietary unsaturated n-6 and n-3 fatty acids, growth, learning, visual activity are impaired in rats and severe structural and metabolic disorders take place (Burr and Burr, 1929; Holman, 1970; Neuringer et al, 1988; Vergroesen and Crawford, 1989) . These perturbations underline the important functions of essen 7 tial fatty acids (EFA). Indeed EFA are important in membrane structure as major components of phospholipids for the integrity and fluidity of intracellular and plasma mem, branes (Kinsella, 1991 ) . In this regard, they modulate activity of membrane-bound receptors, enzymes, molecule carriers and ionic channels. In addition, several of them, namely dihomo-y linolenic (DGLA, , arachidonic (AA, ) and eicosapentaenoic (EPA, 20:5n-3) acids can be easily converted into a wide range of eicosanoids including prostanoids (prostaglandins), thromboxanes, prostacyclines and leukotrienes. These have potent biological effects regulating such important physiological functions as reproduction, heart and vascular physiology and immune functions (Curtis-Prior, 1988) . Finally, n-6 fatty acids are often associated with cholesterol in plasma (18:2 and/or 20:4n-6) and in adrenals (adrenic acid, 22:4n-6) (Lemarchal et al, 1992) .
In the n-6 family, LA is the major essential fatty acid and no more than 1-2% of calories is required to relieve symptoms of essential fatty acid deficiency in rats (Kinsella, 1991 But to ensure at best the biological functions of essential fatty acids, intake of 3-6% is generally recommended. Higher amounts have sometimes been proposed in adults, since LA is beneficial in reducing LDL-cholesterol, atherosclerosis and coronary heart disease. But recent results are indicative of a positive relationship between LA intake and coronary heart disease (Hodgson et al, 1993) . It seems prudent, therefore, not to promote increased consumption of this essential fatty acid. An intake of 7-10 g LA per day seems reasonable. On the other hand, intake of AA probably decreases the need for LA, but the optimum ratio between these 2 essential n-6 fatty acids is not known.
LNA, the precursor of EPA and docosahexaenoic acids (DHA) is also required, especially in the diet of pregnant women and nursing mothers as a source of DHA for neural and visual tissues during development of the embryo and neonate (Kinsella, 1991 From results of different authors (Holman et al, 1982; Bjerve et al, 1987; Bourre et al, 1989; Guesnet et al, 1993) , the optimal requirement for LNA could be 0.5-1 % of calories, while requirements for EPA and DHA would be 0.4%. According to Bjerve et al (1989) , the optimal intake of LNA would be 860 to 990 mg per day, and 350-400 mg for EPA and DHA. The optimal balance between EPA and DHA was not proposed by these authors.
Since DHA is a major fatty acid component of the grey matter of the cerebral cortex and of the photoreceptor membranes of the rod outer segment of the retina and since deprivation of LNA has been associated with impaired learning and visual activity (Neuringer ef al, 1988) , the need for n-3 essential fatty acids has been estimated to be higher in the early stages of life, to ensure optimum development and function of neural and visual tissues, ie 0.7-1.2% of calories according to Lemarchal et al (1992) . A general agreement is that intake of n-6 and n-3 essential fatty acids ranging from 4:1 to 6:1 is prudent (Neuringer et al, 1988) . Most human milks analyzed contain around 1-2% n-3 fatty acids and the n-6/n-3 fatty acid ratio is within the range suggested. It may reflect the need of the neonate for optimal growth, depending on tissue AA content (Carlson etal, 1992) and optimal neural and visual development, depending on tissue DHA content (Uauy et al, 1992) .
DIETARY SOURCES OF ESSENTIAL FATTY ACIDS
As already mentioned, since they cannot be synthesized de novo, n-6 and n-3 polyunsaturated fatty acids must be provided in the diet. Plants are the principal sources of these fatty acids. Unlike animals, plants possess the capacity to insert double bonds between the existing n-9 double bond and the methyl end of oleic acid (Demandre et al, 1986) . Edible vegetable oils, such as sunflower, corn or peanut oil, constitute a major source of LA (Kinsella, 1991 ) . Table I shows that 65% of the sunflower oil fatty acids are LA. The amount is still higher in safflower oil (75-80%). In addition, several oils provide LNA, soybean oil (8%), low-erucic acid rapeseed oil (9%) and walnut oil (13%). The chloroplast membranes of green leafy plants are very rich in LNA but the total amount of the acid provided by these foods is modest since they do not contain large amounts of lipids (Kinsella, 1991 Animal feeds generally contain low amounts of LA. Human milk supplies the neonate with a relatively high quantity of LA (10-13%) (Martin etal, 1993) . On the contrary, bovine milk and the dairy products are poor sources of essential fatty acids (Maniongui et al, 1991 Longer-chain essential n-6 and n-3 fatty acids are generally provided in food from animal sources, ie liver, kidneys, eggs, whereas marine foods are good sources of EPA and DHA (n-3).
Fresh water fish contains both n-6 and n-3 very long-chain fatty acids (Kinkela and B6zard, 1993) . Human milk also provides the neonate with very long-chain essential n-6 and n-3 fatty acids (Martin ef al, 1993) . Several vegetable oils contain essential fatty acids located beyond the rate-limiting A6-desaturation step. Evening primrose, borage and blackcurrant oils contain significant amount of y-linolenic acid (GLA, ).
Blackcurrant oil also contains stearidonic acid (18:4n-3) (Lawson and Hughes, 1988a dealt with the question of digestion and absorption of EFA. A previous review (Nelson and Ackman, 1988) had been principally concerned with n-3 PUFA.
Dietary fatty acids are mainly present in triacylglycerols (> 95%). The others are provided by phospholipids and cholesteryl esters, the dietary intake of which is important since they contain high proportion of very long-chain EFA S .
The processes of lipid digestion and absorption have been reviewed several times in the last few years (B6zard and Bugaut, 1986; Bernard and Carlier, 1989; Thomson et al, 1989; Carlier ef al, 1991 (Lawson and Hughes, 1988b) . However, hydrolysis takes place, probably less rapidly but completely. The absorption could be impaired because of lack of the 2 monoacyl-sn-glycerols necessary for triacylglycerol resynthesis in enterocytes. Indeed absorption was considerably increased when ethyl esters were accompanied by dietary triacylglycerols (Lawson and Hughes, 1988c; Yang et al, 1989) .
The position of fatty acids in the triacylglycerol molecules is another factor affecting their hydrolysis and absorption. Triacylglycerols are partially hydrolysed in the stomach in man in the presence of a gastric lipase. It preferentially hydrolyzes fatty acids in the external sn-1 and sn-3 positions, with the sn-3 more rapidly cleaved than the sn-1 position (Ransac ef al, 1990 (Litchfield, 1972) and even in pork liver triacylglycerols, whereas it is not true in depot fats (Christie and Moore, 1970b) . In humans, the coefficient of digestibility of the most common vegetable oils in 97-98%. Only hydrogenated oils, comprising high amounts of saturated and isomeric fatty acids, have lower coefficients (Deuel, 1955 (Deuel, 1955 (Brockerhoff et al, 1968 (Chen et al, 1985; Carlier et al, 1991) (Kinsella, 1991) . Secondly, the L-FABP (liver-fatty acid binding protein) present in enterocytes, contrary to the I-FABP (intestinal-FABP), might exhibit higher affinity for PUFA than for others (Lowe et al, 1987) (Sprecher, 1981) . These reactions, which occur principally on endoplasmic reticulum membranes (Brenner, 1989) , require activated acyl-CoA esters. The activation is rapid and not rate limiting (Naughton, 1981 (Sprecher, 1989 (Bernert and Sprecher, 1975 (Sprecher, 1981) . Apparently elongation reactions are not ratelimiting (Bernert and Sprecher, 1975) . Elongation and desaturation of 20:4n-6 and 20:5n-3 principally take place in endoplasmic reticulum. However, some transformations were observed to occur in peroxisomes (Mimouni et al, 1991 ) . The capacity of tissues or organs to synthesize n-6 and n-3 long-chain PUFA from LA and LNA, respectively, depends on the presence of active desaturase and elongase enzymes. The relative activity of these enzymes determine the relative amounts of products formed. Brenner (1971) showed that desaturation activity is not evenly distributed in all the organs. He studied the conversion of LA to GLA by A6-desaturation in microsomes from different organs. If the activity in liver was taken as 100, the activity found in different organs were: adrenals (142), testicles (45), heart (8), kidneys (12), and brain (14), while no activity was detectable in lung and epididymal fat. In adult mice, Bourre etal (1990) showed that A6 desaturation activity in brain was ca 6% that found in liver. Thus, important organs such as brain heart and kidney, greatly depend on the liver for the synthesis and supply of long-chain PUFA. However, the liver is not the only organ to provide tissues with longer chain fatty acids synthesized from LA. As mentioned above, the small intestine can synthesize and secrete AA from LA (Caselli et al, 1993) . diet, the conversion of DGLA into AA by A5-desaturation was 3-fold higher after 15 min of incubation, compared with the activity of liver microsomes from rats fed a commercial diet. The increase in A6-and A5-desaturation activity may reflect a response to ensure maximum synthesis of PUFA from 18:1 n-9 (n-9 family) to maintain the fluidity of membranes. In this view, Brenner et al (1981) Blond and Lemarchal (1984) showed that A6-desaturation of LA was highly decreased while A5-desaturation of DGLA was also decreased but to a lesser extent. This was confirmed by observations in vivo by Bourre et al (1989) . Garg et al (1988a) also observed in vivo that, when present in the diet, LNA contained in high amounts in linseed oil, also evoked inhibition (by 30%) of 46-desaturation when compared to a control diet (beef tallow). On the contrary, the A5-desaturation rate was increased (x 1.5) (Garg et al, 1988a) . However, in similar experiments, Choi et al (1989) and Christiansen et al (1991) showed that the A6-desaturase activity was increased (+50%). The 45-desaturase activity was also increased and to higher extent (x 3.5) than was observed by Garg et al (1 988b). These discrepancies probably originate from differences in the control diet. Garg etal(1988a,b) (1980) showed that the level of fat affected the composition of liver fatty acids. The AA content increased from 11 to 21 % in rats consuming 5 and 20% coconut oil respectively for 33 weeks, apparently indicating that A6-and 45-desaturases were stimulated by the high fat diet, although differences in AA utilisation may be also involved.
Results obtained with the long-chain n-3 fatty acids, EPA + DHA are less controversial. These acids found mainly in fish oils markedly depress A6-desaturase enzyme (Choi et al, 1989; Christiansen et al, 1991 ) . They also depress A5-desaturase activity (Garg et al, 1988b figure 2 confirm what was previously demonstrated (Blond et al, 1989) phospholipids of rats fed the fish oil diet. It was even increased in kidney phospholipids of obese rats, but not of lean rats. Since heart and kidney exhibit low capacity of desaturation, the unaltered fatty acid profile of the phospholipids of these organs could result from a preferential uptake of the long-chain EFA from the blood lipids.
Dietary n-6 fatty acids also alter desaturation rates. Periago etal (1989) (1983) observed that the activities were not affected by dietary GLA. However, Choi and Sugano (1988) found a decrease in A6-desaturase activity in 8-month-old but not in 3-week-old rats. On the other hand, Biagi et al (1991) showed an increase in A6-desaturation rate of LA and particularly of LNA. In n recent experiments, we observed agedependent variations in A6-desaturation of LA and LNA and in A5-desaturation of DGLA in liver from Wistar rats fed GLA (unpublished results). In obese Zucker rats, dietary GLA bypasses the A6-desaturase and tends to correct the low AA content of tissues (Girault et al, 1992) .
Very few experiments have dealt with dietary AA (20:4n-6). In the same set of experiments as above on Zucker rats, we observed very similar effects as with the n-3 long-chain fatty acids EPA + DHA (fig 2) , namely a marked decrease in A6-desaturation rate of LA, no effect on A6-desaturation rate of LNA and a decrease in A5-desaturation of DGLA but less pronounced than A6-desaturation of LA (unpublished results).
In summary, with regard to the n-6 and n-3 EFA, the precursors 18:2n-6 and 18:3n-3 highly stimulate the desaturases involved in the biosynthesis of longer chain PUFA (20:4n-6, 20:5n-3, 22:6n-3), while these acids present in the diet markedly decrease A6-desaturation of 18:2n-6, less markedly A5-desaturation of 20:3n-6, but do not alter A6-desaturation of 18:3n-3. This explains why biosynthesis of 20:4n-6 was decreased by dietary fish oil. However, dietary 20:4n-6 also decreased 22:6n-3, in phospholipids according to our results. As stated by Zevenberger and Houtsmuller (1989) , the A6-desaturase system alone does not totally determine the PUFA levels in tissue lipids. Other factors, such as the incorporation rate of PUFA in tissue phospholipids are also involved.
Other fatty acids are likely to modify desaturation rates. Oleic acid (18:1 n-9) can also inhibit A6-desaturase activity but high intake levels are required (Holman, 1964) . Data from Periago et al (1989) also indicate that dietary 18:2n-6, compared to 18:1 n-9, was much more efficient in stimulating A6-desaturation rate.
Trans-fatty acids have been reported to inhibit the conversion of LA to AA, especially the A6-desaturation step, as pointed out in previous reviews (Kinsella etal, 1981; Emken, 1984) . This effect could be due to essential fatty-acid deficiency. On the contrary, A5-desaturation was either increased (Blomstrand et al, 1985) or not affected (De Gomez Dumm et al, 1983; Mahfouz et al, 1984) . Results by Blond etal (1990) (Cao et al, 1993) . They induced a marked decrease in AA content of tissue phospholipids in rats.
The mechanism by which dietary fatty acids modify the desaturase activity may vary according to the fatty acids. The A6-desaturase is sensitive to feed-back inhibition by the procucts of desaturation and elongation (Brenner, 1981) , which is consistent with its high depression by long-chain n-6 and n-3 polyunsaturated fatty acids. Leikin and Brenner (1989) (Clark and Jump, 1993) .
Modification by dietary lipids of the phospholipid fatty acid profile of membranes in which the desaturase systems are anchored are also likely to modify the expression of desaturation activity through changes in fluidity.
Nutrients other than fatty acids modulate desaturase activities. Garda and Brenner (1985) reported that, in vitro, the incorporation of cholesterol into rat liver microsomes enhanced the A6-and A5-desaturase activity, probably by decreasing membrane fluidity. On the contrary, in vivo, cholesterol incorporated into diet decreased the 4 6-and A5-desaturase activity by a mechanism yet to be elucidated (Leikin and Brenner, 1987; Garg et al, 1988a,b (Narce et al, 1988 (Brenner, 1989) . Ingested ethanol was also observed to decrease A6-and A5-desaturase activities (Nervi et al, 1980; Wang and Reitz, 1983 (Cunnane and Wahle, 1981) while it had no effect on A6 desaturation in liver and decreased the rate of A5 desaturation (Cunnane, 1988) . High sodium chloride intake influences A6-and A5-desaturation rate in rat liver microsomes. When 10-week-old male Wistar rats received 3% NaCl in drinking water for 60 d, the A6-desaturation of LA and A5-desaturation of DGLA in liver microsomes were enhanced by 50 and 75% respectively . On the contrary, in another set of experiments in 4-week-old genetically normotensive rats (WKY = Wistar-Kyoto) receiving 1 % NaCI in drinking water for 4 weeks, the A6-and A5-desaturation rates in liver microsomes were decreased by 25 and 28% respectively (Poisson et al, 1993b (Friedmann et al, 1966) .
In the genetically diabetic rat (BB), A6-and A5-desaturation are similarly defective and are restored by insulin injection (Mimouni and Poisson, 1990) . As shown in figure 3 , when BB rats were equilibrated by insulin injection (3 h), the A6-and A5-desaturation rates were similar to values in control Wistar rats. When insulin had decreased in blood (17 and 48 h), the desaturation rates had considerably decreased, especially the A5-desaturation of DGLA. Elongation of DGLA was also demonstrated to be insulin dependent (Mimouni etal, 1992) . Very recently, Mimouni et al (1994) (Poisson and Cunnane, 1991) . ). Glucagon and epinephrine are antagonistic to insulin and depress A6-and A5-desaturase activity in rat liver microsomal preparations (De Gomez Dumm etal, 1975 , 1976 . Glucagon also prevents the refeeding-induced activation of A6-desaturation in previously fasted rats. Depression of A6-desaturation by glucagon and epinephrine is thought to be mediated by stimulation of adenyl cyclase and the subsequent increase in intracellular cyclic AMP, because dibutyryl cyclic AMP induces the same effect as glucagon (Brenner, 1977) . Glucagon and cAMP also inhibit the phosphorylation of acetyl CoA carboxylase, thereby inhibiting formation of malonyl-CoA. This may decrease the elongation rate of 18:3n-6, the product of A6-desaturation of 18:3n-6. The resulting increased concentration of 18:3n-6 may reduce the activity of A6-desaturation by feedback inhibition (Brenner and Peluffo, 1969) .
Similarly to glucagon and epinephrine, the glucocorticoids also affect the metabolism of glucose and fatty acids. They also inhibit 46-desaturase activity (Brenner, 1981 However, they require more time than epinephrine to inhibit desaturation. The delay was attributed to suppression of protein synthesis. Pituitary adrenal corticotrophic hormone (ACTH) causes a decrease in A6-and A5-desaturation activity in rat liver and adrenal glands (Mandon et al, 1986) . Since ACTH stimulates glucocorticoid secretion, the effect of the hormone may be direct or/and indirect.
ACTH and glucocorticoids, the secretion of which has a circadian rhythm, may be involved in the circadian rhythm of desaturase activities, being lowest around 8 am in normal day-night cycle (Brenner, 1981 ) .
Thyroid hormones are necessary for A6-desaturation since hypothyroidism greatly decreased the A6-desaturation rate of LA in rat liver microsomes (Faas and Carter, 1982) . While treatment of hypothyroid rat restores this activity to normal values, hyperthyroidism is associated with a decrease in A6-desaturation (Hoch, 1981; Faas and Carter, 1982) . The lower A6-desaturation rate in liver microsomes from obese Zucker rats, compared to their lean littermates, were also ascribed by Blond et al (1989) to hypothyroidism in these animals.
The levels of thyroxine, glucocorticoids, epinephrine and glucagon increase during fasting (Brenner, 1981) Oestradiol, injected to ovariectomized female rats, decreases the A6-desaturase activity in liver microsomes (Gonzales et al, 1986 (Kinsella, 1991 ) .
The developing brain and central nervous system contain substantial amounts of lipids, both in white matter and myelin (50-70%) and in grey matter consisting primarily of neuronal cells (nearly 40%) (Purvis et al, 1982) , that is appreciably more than in most body organs, including liver, kidney and heart. Total phospholipids of brain also have distinctive fatty acyl chain composition, since the ratio of n-6 to n-3 fatty acids is close to 1:1 compared to 4:1 in liver, kidney and heart (Bourre et al, 1989 ). The 20:4n-6 is the prominent member of the n-6 family, accounting for 10-15% of total fatty acyl chains while, in the n-3 family 22:6n-3 predominates at 6-15% of the total. To achieve this tissue-specific composition during normal brain growth and development requires an appropriate supply of PUFA, both in quantity and in balance between the n-6 and n-3 fatty acids.
Requirements for PUFA are particularly critical for the developing fetus, because of its rapid growth and the early development of its brain. PUFA of the n-6 and n-3 series, or their precursors LA and LNA, are provided from the mother's blood. When the precursors are provided, they have to be converted into PUFA by the fetus. In rats, liver microsomes were demonstrated to be capable of transforming 18:2n-6 into 18: 3n-6 by 46-desaturation (Satomi and Matsuda, 1973; Pascaud and Strouve-Vallet, 1985; Ravel et al, 1985) . They were also capable of transforming 20:3n-6 into 20:4n-6 by 45-desaturation .
The 46-desaturation of 18:2n-6 was also detected in fetus brain microsomes in rats (Pascaud and Strouve-Vallet, 1985) and in mouse brain homogenates (Bourre et al, 1990) . Recent in vivo experiments (Green and Yavin, 1993) in which labelled 18:3n-3 and 18:2n-6 were intracranially injected into near-term fetal rats, clearly showed that these acids were converted to long-chain polyenoic derivatives in the fetal brain.
Therefore, the fetus can, at least in part, supply its own n-6 and n-3 PUFA requirements. However, especially at the early steps of development, it also relies on its mother's supply.
In animals, the liver is the principal organ capable of synthesizing PUFA from the LA and LNA precursors and to secrete these long-chain fatty acids into the blood. However, in pregnant females, placenta can also be a source of PUFA in certain species. While no activity of A6-and A5-desaturations was detected in rat placenta microsomes , the ovine placenta was shown to desaturate 18:2n-6 into trienoic and tetraenoic fatty acids (Shand and Noble, 1981 The existence of desaturation activity in human placenta is still controversial. Certain authors detected some biosynthesis activity (Zimmermann et al, 1979) , while others did not .
Therefore, the developing fetus must depend largely on placental transfer of maternal long-chain EFA, particularly for n-3 fatty acids, highly present in neural tissues. This underlines the importance of EFA intake and of the liver desaturation capacity in pregnant women.
After birth, the neonate must also principally rely on mother's milk for supply the long-chain fatty acids for tissue growth (Martin et al, 1993), although A6-and A5-desaturation activities are present in neonates aged 2-14 d (Poisson et al, 1993a) , as they are in human adults (Blond ef al, 1981 ) .
Because of its importance, the brain deserves particular alteration. What is the capacity of the developing brain for conversion of extracellar supplies of 18:3n-3 and 18:2n-6 into essential products such as 20:5n-3, 22:6n-3 and 20:4n-6? To what extent does the brain depend on the liver for supplying the essential PUFA? These are important questions regarding the EFA availability in neonates.
In vitro preparation from brain and liver (Cook, 1978) showed that in the very young 10-day-old rats, conversion of 18:2n-6 and 18:3n-3 by A6-desaturation was much higher in brain than in liver. The A5-desaturation of 20:3n-6, although very low in brain, was also significantly higher than in liver. Bourre et al (1983) have demonstrated that mouse brain cells were not capable of synthesizing 22:6n-3 from 18:3n-3 but were capable of taking it up from the medium. The brain 22:6n-3 would thus have a hepatic origin, being specifically taken up by endothelial cells of brain from the blood lipids (Bourre et al, 1983; Scott and Bazan, 1989) . Indeed, as shown by Anderson and Connor (1988) , rat brain exhibits a specific capacity in vivo to take up 22:6n-3, although less than liver.
On the other hand, Cook (1991) thinks that the brain is capable of synthesizing 22:6n-3. Indeed Spector and Moore (1992) by using cultured endothelial cells from brain vessels, cultured astrocytes, and cultured neurons from rats, clearly showed that endothelial cells and astrocytes actively cooperated in synthesizing 22:6n-3 and providing it to neurons. Endothelial cells extensively convert 18:3n-3 to 20:5n-3 while astrocytes convert the latter into 22:6n-3 available for neurons. Synthesis of 20:4n-6 from 18:2n-6 would follow the same pathway.
As animals are growing older, the capacity of liver to desaturate n-6 and n-3 fatty acids increases while that of brain decreases (Cook, 1991 However, at high ages desaturation in vitro of fatty acids in rat liver (Peluffo and Brenner, 1974; Bordini et al, 1988; Choi et al, 1989; Biagi et al, 1991) and in mouse liver (Bourre et al, 1990 ) was shown to decrease. In a recent study (Maniongui etal, 1993) , we have measured A6-desaturation of 18:2n-6 and 18:3n-3 and 45-desaturation of 20:3n-6 in liver microsomes from rats fed a balanced diet throughout their life from 1.5 to 24 months of age. The results were expressed as specific activity and as liver capacity to desaturate by taking into account the liver weight which increased from 6.8 g at 1.5 month to 14.1 g at 24 months. The results illustrated in figure 4 show that specific activity of 18:2n-6 had not decreased from 1.5 to 24 months of age, despite some variation throughout the life. Since the liver weight increased, the liver capacity to desaturate 18:2n-6 increased up to 6 months to reach a plateau from 6 to 24 months. The timecourse of A6-desaturation of 18:3n-3 was different from that of 18:2n-6, since it increased from 1.5 to 3 months and then regularly decreased. However, the liver capacity to desaturate 18:3n-3 was not different at 1.5 and 24 months. The A5-desaturation of 20:3n-6 varied with age very differently from A6-desaturation of 18:2n-6. It was nearly 6-fold higher at 1.5 months and fell to nearly the same value at 3 months. From then on, A5-desaturation slowly increased up to 24 months. At this age, the liver capacity to desaturate 20:3n-6 was not significantly different from that measured at 1.5 months.
These data demonstrated that the liver capacity to synthesize 20:4n-6 from 18:2n-6 did not decrease with age in rats. This was reflected in 20:4n-6 content of liver microsomal phospholipids ( fig 5) and of erythrocyte lipids, which increased from 1.5 to 20 months. In these experiments, the liver capacity to convert 20:4n-3 to 20:5n-3 by A5-desaturation was not determined, because commercial labelled precursor was not available. The liver capacity to desaturate 18:3n-3 was not decreased at 24 months, and the liver microsome phospholipid content in 22:6n-3 was not significantly different at 1.5 and 24 months (12.9 and 12.5 mol% respectively).
These results clearly show that in rats fed a balanced diet, if desaturation capacity of liver is evaluated in the whole organ, no decrease occurs from 1.5 to 24 months. This is reflected in the unchanged or even increased content in polyunsaturated n-6 and n-3 fatty acids of the membrane lipids studied.
In humans, the liver desaturation activities are much lower than in rats Blond et al, 1981 Despite that, several studies have shown that few differences exist between elderly and young subjects with respect to the n-6 and n-3 fatty acid content of serum (Holman et al, 1979; Asciutti-Moura et al, 1988) , erythrocyte (Driss et al, 1988) and platelet (Vericel et al, 1988) From these data, it is evident that longchain essential n-6 fatty acids were oxidized to C0 2 at a very low rate, much lower than the 'parents' 18:2n-6 and 18:3n-3. This is evidence that when provided as very longchain fatty acids, the EFA are required in lower amount in the diet than the precursors 18:2n-6 and 18:3n-3.
The same type of experiment has been carried out in humans using [ 13 C]-labelled fatty acids (Jones et al, 1985) . [ The maximum of 13 C0 2 excretion was observed 6 h after oral administration for the first 2 fatty acids. It was delayed for 18:0. During the 6th hour, 13 C recovered by oxidation of 18:1 n-9 was around 2.8% of the absorbed dose. It was 2.0% for 18:2n-6 and 0.1 % for 18:0, that is 28-fold less than for 18:1 n-9.
As in rats (Leyton ef al, 1987) , 18:2n-6 in humans is oxidized at lower rate than 18:1 n-9. Oxidation by tissues thus limits the availability of the absorbed LA. The same is probably true, in humans, for LNA as well.
In the whole body, the oxidation rate of fatty acids by tissues depends on the rate of their uptake by the cells and the rate of their oxidation inside the cells. The uptake rate of fatty-acids from the blood depends itself on tissue or organ specificity, on fatty-acid specificity and on whether or not the fatty acid is esterified. Although the EFA are principally present in the blood in an esterified form, especially following their intestinal absorption most of the experiments undertaken for studying differential uptake by tissues have utilized free fatty acids. In that case, the data reported above and those obtained by Anderson and Connor (1988) (Ong et al, 1977 (1986) observed that, at a given free fatty acid/serum albumin molar ratio, the uptake of unsaturated fatty acids was identical whatever the fatty acids. This confirmed results by Kohout et al (1971) in perfused liver for saturated and unsaturated fatty acids. On the contrary, Anderson and Connor (1988) have shown that, in vivo, liver of very young rats took up 22:6n-3 4 times more rapidly than 18:3n-3.
The mechanism of fatty-acid uptake by animal cells has not been fully elucidated. In spite of strong evidence for carrier-mediated uptake and possibly for active transport, it is still argued that fatty-acid uptake occurs by spontaneous and non-specific diffusion of fatty acids across the plasma membrane (Schulz, 1991 ) .
Inside the cell, fatty acids are channelled to different metabolic pathways, possibly by fatty-acid binding proteins (FABP) (Schulz, 1991 ) . In most cells, particularly in hepatocytes, the 2 major routes are esterification in endoplasmic reticulum and oxidation in mitochondria and peroxisomes. In liver, regulation of oxidation of fatty acids generally determines their availability for esterification. However, the esterification pathway is also regulated. Fish oil diets that greatly increase mitochondrial and peroxisomal poxidation of fatty acids, conversely decrease phosphatidate hydrolysis and thence glycerolipid synthesis (Halminski et al, 1991) . ).
The tissues and organs in animals display different oxidative capacities. In experiments with homogenates of liver, heart muscle and quadriceps muscle, Reubsaet et al (1989) have observed that the fatty-acid oxidation rate in the heart was 52 to 93% that of the liver, whereas the rate in the skeletal muscle was only 9 to 35% of the liver capacity.
The contribution of mitochondria and peroxisomes to fatty-acid oxidation highly depends on the fatty acid (Osmundsen et al, 1991) . In their study on tissue homogenates, Reubsaet etal (1989) (1986) observed that 22:4n-6 and 20:5n-3 were oxidized to a greater extent in peroxisomes than 18:1 n-9, 18:2n-6, 20:4n-6 and 22:6n-3.
In this experiment, 75% of 22:4n-6 oxidation was in peroxisomes. The difference between the 2 experiments with regard to the location of 22:4n-6 oxidation may be due to the model used.
Osmundsen etal(1987) have measured fatty-acid oxidation on isolated mitochondria and peroxisomes. They observed that in mitochondria, 18:1 n-9, 18:2n-6, and 18:3 n-3 were oxidized at nearly equal rates, while 18:3n-6, 20:4n-6 and 22:6n-3 were poorly oxidized. In peroxisomes, 18:3n-3, 18:3n-6 and 22:6n-3 were particularly well oxidized.
Clouet et al (1989) have observed that the oxidation rate of 18:3n-3 was higher than that of 18:2n-6 and 18:1 n-9 in isolated rat liver mitochondria. The reason was the specific activity of the enzyme carnitine palmitoytransferase I (CPTI) measured in the mitochondrial outer membranes. Figure 7 shows that the CPTI activity towards 18:3n-3 was higher than towards 18:2n-6 and 18:1 n-9 and that the activity increased with the ratio of fatty acid/albumin and more rapidly for 18:3n-3. Gavino and Gavino (1991) have confirmed these results by measuring the CPT initial velocity and additionally showed that the initial velocity was very low for 20:4n-6 and 22:6n-3 but relatively high for 20:5n-3, studied as acyl-CoA. They suggested that acyl-CoA synthesis may also be important in the control of the entry of fatty acids into the mitochondria, in addition to specificity of CPTI to fatty acyl-CoA. In this view, Singh et al (1987) (Osmundsen ef al, 1991 The activity is very sensitive to nutritional factors.
In livers of rats fed high-fat diets, peroxisomal (3-oxidation is stimulated, in particular when the diet contains a high proportion of very long-chain fatty acids, as in hydrogenated fish oils, known to be poorly P-oxidized in mitochondria (Osmundsen et al, 1991) . Polyunsaturated n-3 fatty acids are particularly potent stimulators of oxidation. Repeated administration of EPA (20:5n-3) ethyl ester to rats enhances the activity of enzymes involved in mitochondrial and peroxisomal fatty-acid oxidation (Aarsland et al, 1990) . Willumsen et al (1993) have recently confirmed that prolonged administration of EPA to rats increased peroxisomal and mitochondrial fatty-acid oxidation in isolated hepatocytes. Fish oil was also observed to stimulate peroxisomal capacity to oxidize fatty acids, but not safflower oil containing nearly 85% 18:2n-6 (Halminski et al, 1991 ). Vamecq et al (1993) confirmed these results and considerably extended studies on regulation of fatty acid mitochondrial and peroxisomal oxidation by n-3 PUFAs. When rats were given diets enriched in n-3 and n-6 fatty acids, varying in n-3/n-6 fatty acid ratio, peroxisomal [3-oxidation of lauroyl-CoA in liver increased with increasing ratio, being nearly 3-fold higher when the ratio increased from 0.12 to 10. In these circumstances, mitochondrial [3-oxidation of butyryl-CoA was not increased in liver, whereas the activity of mitochondrial acyltransferases was enhanced with the higher n-3/n-6 fatty-acid ratio. In heart, the peroxisomal and mitochondrial fatty-acid oxidation was also increased but to a lesser extent and only at high ratios. Ultrastructural studies additionally showed that in hepatocytes of rats fed the high fat diet with the highest n-3/n-6 fatty-acid ratio, the number and the fractional volumes of peroxisomes and mitochondria were higher than with the lowest ratio.
These data definitely establish that dietary n-3 PUFA induce the enhancement of peroxisomal fatty acid oxidation and also mitochondrial oxidation, but less strongly.
The beneficial effect of n-3 PUFA is to lower hypertriglyceridaemia, by decreasing liver VLDL secretion, in animals and humans. A possible adverse effect is to decrease the availability of n-6 polyunsaturated fatty acids (20:4n-6) reinforcing in this way the inhibiting effect of polyunsatured n-3 fatty acids on A6-and A5-desaturation capacity of n-6 fatty acids in liver microsomes (fig 2) .
In conclusion, n-6 and n-3 essential fatty acids should be provided with the diet in balanced proportion. An n-6/n-3 fatty acid ratio comprised between 4 and 6 is generally recommended as the most beneficial. They must also be provided in sufficient amounts to optimise their biological functions but not in too high amounts to avoid possible adverse effects. In healthy subjects, a dietary intake of both parent EFA (18:2n-6, 18:3n-3) of 4-6 or 7% of total energy intake could be recommended. But it depends on the other dietary components: very longchain n-6 and n-3 fatty acids, the other dietary fatty acids, saturated, monounsaturated, trans-fatty acids, protein and starch etc. It also depends on the physiological state: pregnancy, nursing, growth or aging. Pathological states are likely to greatly modify the EFA requirements because of defects in the very-long-chain PUFA biosynthesis. However, in healthy individuals, despite the numerous factors likely to influence the availability of EFA, a regular and balanced diet usually meets the tissue requirements in n-6 and n-3 EFA.
